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ABSTRACT
The Human Disease Ontology (DO) (www.diseaseontology.org) database, has significantly expanded
the disease content and enhanced our userbase and
website since the DO’s 2018 Nucleic Acids Research
DATABASE issue paper. Conservatively, based on
available resource statistics, terms from the DO have
been annotated to over 1.5 million biomedical data
elements and citations, a 10× increase in the past
5 years. The DO, funded as a NHGRI Genomic Resource, plays a key role in disease knowledge organization, representation, and standardization, serving as a reference framework for multiscale biomedical data integration and analysis across thousands
of clinical, biomedical and computational research
projects and genomic resources around the world.
This update reports on the addition of 1,793 new
disease terms, a 14% increase of textual definitions
and the integration of 22 137 new SubClassOf axioms defining disease to disease connections representing the DO’s complex disease classification.
The DO’s updated website provides multifaceted etiology searching, enhanced documentation and educational resources.

* To

GRAPHICAL ABSTRACT

INTRODUCTION
Broadly useful genomic resources provide rapid access to
collected knowledge in human-readable and computationready formats, thus breaking down interoperability barriers by harmonized data representations through the integration of semantic standards. Hence, building a standardized way of linking related genomic knowledge between resources makes disease-related data more Findable, Accessible, Interoperable, and Reusable (FAIR) (1). For example,
the Alliance of Genome Resources (AGR) (2) has developed
a unified model organism research platform that facilitates
linkages between genes, alleles, human disease models, and
human genes represented in the Model Organism Databases
(3–9), utilizing ontologies and controlled vocabularies (Human Disease Ontology (DO), www.disease-ontology.org),
Online Mendelian Inheritance in Man (OMIM), Mammalian Phenotype Ontology (MP), Human Phenotype Ontology (HPO) and UBERON (10–14)). Among these ontology resources, the DO plays a central role in classifying
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The DO’s CONTENT and WEBSITE EXPANSION
Here, we report on the significant enhancements to the DO
database since 2018, including the expansion of the DO’s
disease terms, logical definition content and the integration
of additional ontology imports. We also report enhancements to the DO website that enable multifaceted data exploration and expanded outreach materials and activities.
DO content (terms, axioms and imports) updates
We have augmented the DO’s content, including disease
terms, Relation Ontology (RO) relations (15), and ontology
imports, to support new data models. The 100th GitHub
Release of the Human Disease Ontology (v2021-08-17) included 10 862 disease terms, with 76% (8312) of the disease
terms defined by textual definitions. This release represents
the addition of 1793 new disease terms and a 14% increase
of textual definitions. Disease terms have been added fairly
evenly across the DO classification hierarchy. Disease terms
previously classified as asserted children of ‘genetic disease’
have been reclassified to be both asserted ‘syndrome’ child
terms and inferred ‘genetic disease’ child terms. Notable
new terms include SARS-CoV-2 related diseases and over
1000 OMIM genetic disease subtypes. Given the importance of OMIM as the gold standard reference for human
genetic diseases and the relation of these disease terms to
human genes, integrating and maintaining OMIM crossreferences in the DO is a high priority set of tasks. These
tasks include: refining and maintaining the relations between OMIM phenotypic series and DO terms; identifying
cases where changes in OMIM result in a change in the disease attached to a specific OMIM ID; removing obsolete
OMIM IDs from the DO; and adding new OMIM IDs to
the DO as OMIM adds additional phenotypes and refines
their OMIM phenotypic series representations.

The DO’s expert curators have researched and written
over 8880 textual definitions (to date) following specific
design patterns to capture the most pertinent information
and document their associated 12 739 definition sources,
identifying new knowledge from authoritative sources (e.g.
OMIM, Genetics Home Reference, Gene Reviews, Genetic
and Rare Diseases Information Center (GARD)) (16–18).
The type of ‘source’ has been documented through an expansion of the Evidence and Conclusion Ontology (ECO),
through the development of 11 new ECO codes under the
parent term: ‘curator inference from authoritative source’
to specify if the definition source was a book, database, dictionary (e.g. MedlinePlus, Merriam-Webster, Oxford), encyclopedia (Britannica, MedlinePlus, Wikipedia) or a journal publication (19). ECO codes are programmatically assigned to definition sources as part of the DO release process, with each DO release given a unique, persistent digital
identifier, enabling future analysis based on specific DO releases. The DO’s 100th Release includes 35 984 clinical vocabulary cross references, with new Medical Subject Headings (MeSH), NCI thesaurus and SNOMED CT terms (20–
23) identified through the DO’s bi-annual Unified Medical
Language System (UMLS) (24) update and with Orphanet
(25), OMIM and GARD cross references manually added
during curation of new DO terms. The DO’s integration of
widely accepted clinical vocabulary standards enhances the
DO’s value for linking data compiled within resources. The
DO is a domain ontology and a semantic disease classification, is intended to be reasoned computationally, is formally structured and serves as a disease nomenclature and
disease term harmonization resource supporting development of over 50 application ontologies.
Yearly, a number of complex genetic diseases are reviewed by the DO’s Clinical team to discern the complexity
of genetic predispositions and revise their DO classifications. Terms reviewed since our previous NAR publication
include amyloidosis, Ebstein’s anomaly, hypertrophic cardiomyopathy, conformational diseases (prions), tuberous
sclerosis, fetal alcohol syndrome, inherited metabolic disorders, DiGeorge/velocardiofacial syndrome/Deletion 22
syndrome, Chromosome 22q11.2 deletion syndrome, Alport syndrome, diabetes and asthma. Review of lysosomal
storage diseases is ongoing. Additionally, the content of the
DO has been enhanced to support usage of British English
aliases in the Clinical Interpretation of Variants in Cancer
(CIViC) database, through the incorporation of British
synonyms into the ontology. We identified ∼30 commonly
used clinical terms that have different British synonyms
(e.g. diarrhea vs diarrhoea, hemorrhage versus haemorrhage), adding novel term pairs to the HPO British English
dictionary. We utilized SPARQL Protocol and RDF
Query Language (SPARQL) queries and a ROBOT tool
(26) pipeline to programmatically add British synonyms
to ∼150 DO terms (https://github.com/obophenotype/
human-phenotype-ontology/blob/master/src/ontology/
hpo british english dictionary.csv). The pipeline has been
added to the DO’s Makefile to run each time we build a
new DO release, thus creating British English synonyms
for new DO terms. For example, the DO term ‘neonatal
anemia’ would have the synonym ‘neonatal anaemia’
added as part of the DO’s build process. The current DO
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>10 800 rare, common and complex human diseases and
is utilized by thousands of clinical, biomedical and computational researchers and genomic resources around the
world. The DO’s terms, disease classification and mechanistic models have made the DO the de facto standard for
disease etiology. The DO innovates interoperability between
the DO and other ontologies through the integration of logical definitions formulated via ontology imports to define
disease features and etiology.
The DO seeks to describe the breadth and complexity of
human disease and to provide a stable framework for advanced analysis. Expansion of the DO’s content and disease models further advances our understanding of disease
mechanisms, strengthens the disease information ecosystem
and promotes the dissemination of knowledge that is responsive to new discoveries and paradigm shifts and that
integrates basis science and clinical medicine. The breadth,
number and diversity of the DO’s use cases continues to expand substantially each year, as the DO is utilized to explore
genomic disease associations, and to facilitate development
of effective health informatics tools that guide diagnostics
and to develop disease-phenotype and disease-drug association predictions. Since our previous Nucleic Acids Research
(NAR) DATABASE issue publication (10), we have made
significant improvements and advances to our database.

Nucleic Acids Research, 2022, Vol. 50, Database issue D1257

file includes additional RO relation terms. The RO term,
‘disease has feature’ is utilized to define when a disease,
such as cataracts, is a feature of another disease. Previously,
axioms defining anatomical locations of a disease were
defined using the RO term ‘located in’ which has been
replaced with the RO term ‘disease has location’ to align
with RO revisions.
Axioms

Cross references
As our understanding of human disease changes and
evolves over time it is necessary to review and revise disease
entity relationships between different disease resources. In
the DO, terms from many different disease resources are integrated as database cross-references (xrefs) to DO terms.
We introduced the use of Simple Knowledge Organization
System (SKOS) mapping terms (https://www.w3.org/TR/
skos-reference/) (28) (skos:narrowMatch, skos:exactMatch
and skos:broadMatch) to express mapping relationships
and reconcile differences between the DO’s cross-references.
SKOS mappings enable the DO to distinguish and define
differences in ‘lumping and splitting’ of terms between vocabularies, with the skos:broadMatch utilized where the DO

DO’s ontology trees
The DO’s OBO and OWL trees provide a multi-parentage
view of disease classification. The DO utilizes the ELK
reasoner supporting the OWL 2 EL profile (https://www.
w3.org/TR/owl2-profiles/). The DO’s OWL tree enables exploration of disease via the DO’s imports, thus enabling
exploration of disease through related biomedical information (cancer, anatomical location, cell type of origin);
environmental driver (infectious agents, chemicals, exposures, food allergies); genetic drivers (susceptibility traits,
sequence variants); and clinical variants (phenotypes and
symptoms). These novel views of disease provide a unique
perspective, such as exploring related diseases or disease
mechanisms through the lens of common disease drivers
(genetic risk factors, biological, chemical or ecological factors), phenotypes, symptoms, mode of inheritance, or infectious agent.
Classifications
Integration of up-to-date disease nomenclature refined by
disease re-classifications has further enhanced the DO’s
disease representation. The DO’s disease etiology-based
classification has evolved to be responsive to what is
more useful for our userbase, to provide an anatomical
view of disease and to model environmental drivers of
complex genetic diseases. These include the classification
of pediatric cancers of acute lymphoblastic leukemia, Blymphoblastic leukemia/lymphoma and gliomas to include
the WHO’s molecular subtypes. This collaborative effort
involved working with ClinGen and CIViC and integrating ICD-O (https://seer.cancer.gov/icd-o-3/) cross-reference
mappings for pediatric cancers (29,30). A complete review
and revision of the sarcoma branch was guided by Dr. Radoslav Davidovic at the Center for Multidisciplinary Research, Institute of Nuclear Sciences VINA, Belgrade, Serbia. The DO team, working with the Immune Epitope
Database (IEDB) (31), has reviewed and integrated hypersensitivity, immune and inflammation related diseases.
The DO team has also updated the nomenclature of benign neoplasms to incorporate a revised naming system and
revamped the classification for Alzheimer’s disease, earlyonset and late-onset Parkinson’s disease (coordinated with
Mouse Genome Informatics (MGI) and OMIM). The DO’s
genetic disease classification has been augmented with the
addition of mechanistic data models (multi-genic, mode of
inheritance, symptom and complex disease). This work has
made it clear that reliable and accurate incorporation of
entities from disease resources into the DO requires both
a thorough understanding of disease concepts, coordination and co-development of guidelines and insight into the
nuances of representation of these concepts by various resources. Only through careful review and consultation with
these resources can we provide an integrated view of disease
in the DO.
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The DO’s clinical utility has been enhanced through the integration of the diverse and interconnected etiological genetic risk factors and environmental drivers of disease, to
better represent complex disease by linking DO terms with
those of related biomedical ontologies via highly structured
design patterns. Here, we report on the growing number of
inferred-classifications, empowered by the addition of a significant number of new SubClassOf axioms. The DO has
established a novel complex disease classification, by defining disease to disease connections through the integration
of 22 137 new SubClassOf Axioms, representing a significant increase from the 3612 SubClassOf Axioms reported
in 2018. The DO contains these logical definitions (axioms)
to describe relevant disease drivers, constructed with specific RO terms, as a Web Ontology Language (OWL) object property, to create a restriction between a DO term and
another Open Biological and Biomedical Ontology (OBO)
Foundry ontology term. For example, carcinoma is defined
with an Equivalent Class axiom (‘cell type cancer’ and ‘derives from’ some ‘epithelial cell’) defining the cell type with
Cell Ontology terms (27). Thus the relatedness of each organ system cancer with an epithelial cell of origin (e.g. trachea carcinoma and colorectal carcinoma) is defined via
an ‘inferred’ parentage to carcinoma. Defining these relationships in the DO enables enhanced querying to identify DO terms sharing a common disease driver. Through
this method, we are creating a taxonomy of linked diseases
and allowing the user to investigate indirect links between
diseases. The addition of highly structured design patterns
for a comprehensive set of axioms linking DO and other
biomedical ontologies will enable powerful queries exploring diseases with common etiological mechanisms, thus facilitating a more in-depth understanding of complex disease.

concept is broad and the xref is narrow (represents subtypes), and the skos:narrowMatch utilized where the DO
concept is narrow (DO represents subtypes) and the xref is
broad.
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Modeling complex disease etiology
Representation of the complexity of genetic etiology and environmental drivers of disease within the ontological structure of the DO presents a framework for developing a differential diagnosis resource. Beyond monogenic diseases,
clinical diagnosis is challenged by the complexity of etiologies for multifactorial genetic diseases. The complexity of etiologies for differential diagnosis challenges established bioinformatic knowledge captured in biomedical ontologies. Classification of complex disease necessitates an evolution towards precise disease etiology captured
through clinically-defined semantic assertions. To address
the challenges of representing this clinical complexity, the
DO project has developed a complex genetic disease model
to drive the restructuring of the DO’s knowledge (Figure 1).
As knowledge grows on how interactions between genetic
and environmental factors lead to human disease, there is
a need to incorporate genetic and environmental information into the DO. The pleiotropy of genetic diseases and the
multi-organ impact of environmental factors further challenges the ontological representation of complex clinical
knowledge.
Imports and automated integration
The DO has enhanced identification of related diseases
and enabled querying of diseases by related biomedical
data with the inclusion of a suite of ontology imports.
The DO integrates non-disease ontology terms to define connections between diseases, defined by logical
axioms. For example, querying the axiom (‘has phenotype’ some ‘Abnormal immunoglobulin level’) retrieves
27 autoimmune-related disease terms. These logical
assertions define relationships by connecting diseases

through their shared attributes and allows viewing of
inferred relationships between diseases to build a more
complex multi-parental disease to disease classification.
Utilizing ontology imports enables exploration of disease
terms through their related cell of origin, anatomical
location, symptoms, phenotypes, genetic or environmental
risk factors. The DO’s import files are generated with
each DO release using the ROBOT ‘extract’ command,
which syncs the import file with their source ontologies
(https://disease-ontology.org/resources/DO Imports).
The subset of ontology terms utilized from each import is defined by curated term lists. To maintain a
reasonable size, only part of each ontology import file
that is relevant to DO disease axioms are imported.
The DO’s custom import term lists (see our GitHub
import directory: https://github.com/DiseaseOntology/
HumanDiseaseOntology/tree/main/src/ontology/imports)
are updated and aligned to their source ontologies as
part of the DO’s monthly data release. To date, the DO
integrates 15 import files: anatomy, cell types, chemicals,
(age of) onset, disease drivers, evidence codes, food material, inheritance pattern, omim susceptibilty (genetic risk
factors), phenotypes, sequence (structural and functional
variants), symptoms, taxonomy and transmission methods
(see Figure 1). The onset import is extracted from the
HPO and the omim susceptibility import is maintained
by the DO team. More recent work has focused on the
addition of disease drivers to define environmental factors that contribute to disease etiology, such as chemical
exposures, nutritional deficiencies, mother to child smoking or alcohol exposure as mechanisms of disease. A
subset of these are ‘environmental stressors’, a term in
the Exposure Ontology (ExO) (32) and adopted into the
Environmental conditions, treatments and exposures ontol-
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Figure 1. DO imports for defining environmental drivers and complex genetic disease etiology. The DO’s doid.owl tree integrates terms from 15 other
biomedical ontologies to define features and etiology of human diseases (11,13,14,19,27,34–37, GENO: http://obofoundry.org/ontology/geno, NCBITaxon
ontology: http://www.obofoundry.org/ontology/ncbitaxon.html; the Symptom, Pathogen Transmission, & Disease Drivers Ontologies are part of the DO
project). Axioms are defined by pairing an ontology relation term and one or more ontology terms, such as ‘transmitted by’ some (‘droplet spread transmission’ or ‘airborne transmission’) for COVID-19.
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ogy (ECTO) (https://github.com/EnvironmentOntology/
environmental-exposure-ontology). We have created
and continue to develop a new application ontology
(CC0 license), Disease Drivers Ontology (DISDRIV),
to capture the environmental stressors, as adding the
specific stressors themselves is out of scope for ExO and
ECTO, which plan to represent the upper level terms only.
The DISDRIV ontology is available in GitHub (https:
//github.com/DiseaseOntology/DiseaseDriversOntology).
The DO’s website
The DO’s website has been updated with new features,
including new Community, Curation, Documentation,
and Outreach pages (Figure 2). A new OWL tree view has
been added to the DO website, based on the ‘doid.owl’
file, which enables searches that include any of the DO’s
import files (e.g. cell types, anatomy, inheritance). Users
can, for example, retrieve diseases that are located in the
same body site (anatomical location) or retrieve all diseases
that share a common mode of inheritance (e.g. autosomal
recessive inheritance). The DO website provides publicly
available documentation of curation methods, lists and
links to the DO’s contributors and documented users,
shares services offered via the DO’s website, documents
peer-reviewed publications, and provides access to the
DO’s educational videos on the DO’s YouTube channel
(https://www.youtube.com/c/DiseaseontologyOrgDOID),
a quarterly newsletter and the DO’s Tweets. Enhanced
curation documentation includes: ‘DO SPARQL queries’,

‘ROBOT (automated QC, data release)’, ‘Design Patterns
– Inheritance’, ‘DO Ticket Review Steps’, ‘DO merges
FAQ’ and ‘How is DO FAIR’. The updated DO website
includes monthly release notes and quarterly updated
statistics for assessing usage and richness of content,
including ‘Publications Citing the Disease Ontology Each
Year’, ‘Disease Ontology Terms and Definitions by Release’, ‘Disease Ontology Branch Counts’ and ‘Disease
Ontology Cross-References. The DO’s Community >>
Publications page documents the DO’s ever expanding
use cases and applications. The DO serves as the disease
nomenclature resource across more than 280 biomedical
resources and over 50 biomedical ontologies identified
through the mining of the DO’s PubMed citations. The
DO team has recently identified, via Scopus, more than
1300 DO project citations, a significant increase from the
∼700 reported in February 2021. The two ontology tree
views provide multi-parentage views of the DO’s disease
classification and enable exploration of disease through
related biomedical information. The OBO tree presents
diseases while the OWL tree presents diseases and imports.
For example, to explore the etiology of ‘cancer’ users can
examine anatomical location, cell type of origin; environmental drivers (infectious agents, chemicals, exposures,
food allergies) and/or genetic risk factors (susceptibility
traits, sequence variants) along with clinical variants
(phenotypes and symptoms). This enables novel views
of disease, for example, through the lens of common
symptoms or the mode of inheritance, or infectious agent.
Multifaceted searching enables exploration of the DO’s
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Figure 2. The DO website. Providing educational resources, multifaceted querying of OBO and OWL trees.
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FUTURE DIRECTIONS
Modeling and defining the environmental components of
complex diseases will expand the DO’s repertoire for differential diagnosis exploration. Expanding our understanding
of the underpinnings and impact of genetic variation will

enhance the DO’s multifaceted view of human disease etiology. We plan to enhance the DO’s dissemination through
social media and expanded outreach opportunities.
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